ESE-1 Activators are a class of compounds that enhance the functional activity of ESE-1 by acting on various cellular mechanisms. Forskolin, through the increase of cAMP, activates PKA which can phosphorylate and influence the transcriptional activity of ESE-1. This phosphorylation may enhance the binding of ESE-1 to DNA, facilitating its transcriptional efficacy. Epigallocatechin gallate and 5-Aza-2'-deoxycytidine reduce methylation of the ESE-1 promoter region, which may lead to augmented ESE-1 expression and subsequent transcriptional activity. Similarly, Sulforaphane, Trichostatin A, and Sodium butyrate, as HDAC inhibitors, increase histone acetylation, allowing for a more open chromatin structure and improved ESE-1 access to DNA, which enhances its transcriptional regulation capabilities.
Further, Retinoic acid can induce the expression of genes that act as co-factors or enhancers of ESE-1 activity, while Curcumin, by inhibiting NF-κB signaling, can reduce suppressive inflammatory signaling pathways that hinder ESE-1 activity. Resveratrol, through SIRT1 activation, can lead to deacetylation of histones and transcription factors, creating a conducive chromatin environment for ESE-1. Piceatannol and SP600125, by modulating kinase activities, indirectly influence the transcriptional programs that ESE-1 is a part of, enhancing its transcriptional output. Lithium chloride's inhibition of GSK-3 may also contribute to the stabilization of transcription factors or co-activators that enhance ESE-1's transcriptional activity.
Items 11 to 12 of 12 total
Schermo:
Nome del prodotto | CAS # | Codice del prodotto | Quantità | Prezzo | CITAZIONI | Valutazione |
---|---|---|---|---|---|---|
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $30.00 $46.00 $82.00 $218.00 | 18 | |
Inibitore HDAC che porta all'iperacetilazione degli istoni, potenzialmente in grado di potenziare l'attività di ESE-1 aumentandone l'accessibilità ai promotori dei suoi geni bersaglio. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $65.00 $267.00 | 257 | |
Inibitore di JNK in grado di modulare l'attività di AP-1, potenzialmente in grado di potenziare l'attività di ESE-1 alterando la regolazione trascrizionale dei geni con cui ESE-1 interagisce. |